ST Pharm Co.Ltd (237690) — Cash Flow Reinvestment Rate
ST Pharm Co.Ltd (237690) has a Cash Flow Reinvestment Rate of 0.90x as of September 2025, reinvesting ₩26.39 Billion (capex ₩14.61 Billion plus investments ₩-11.79 Billion) from operating cash flow of ₩29.25 Billion. Explore 237690 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ST Pharm Co.Ltd Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for ST Pharm Co.Ltd across 9 annual periods. Also explore 237690 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ST Pharm Co.Ltd (2015–2025)
Year-by-year capital reinvestment analysis for ST Pharm Co.Ltd. For live market cap and broader valuation context, see ST Pharm Co.Ltd (237690) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 4.60x | ₩64.37 Billion | ₩13.99 Billion | ₩47.29 Billion | ▲ +196.7% |
| 2024 | 1.55x | ₩169.77 Billion | ₩109.45 Billion | ₩83.22 Billion | ▼ -98.4% |
| 2023 | 96.91x | ₩125.83 Billion | ₩1.30 Billion | ₩43.44 Billion | ▲ +926.4% |
| 2022 | 9.44x | ₩66.39 Billion | ₩7.03 Billion | ₩60.66 Billion | ▼ -27.2% |
| 2021 | 12.97x | ₩94.28 Billion | ₩7.27 Billion | ₩51.79 Billion | ▲ +400.0% |
| 2018 | 2.59x | ₩27.93 Billion | ₩10.77 Billion | ₩27.17 Billion | ▲ +408.8% |
| 2017 | 0.51x | ₩27.75 Billion | ₩54.44 Billion | ₩27.70 Billion | ▼ -62.0% |
| 2016 | 1.34x | ₩68.08 Billion | ₩50.78 Billion | ₩16.03 Billion | ▲ +24.8% |
| 2015 | 1.07x | ₩38.47 Billion | ₩35.82 Billion | ₩22.40 Billion | — |